7-(4-bromophenyl)dibenzo[c,h]acridine

7-(4-Bromophenyl)dibenzo[c,h]acridine (CAS 1352166-93-8) is a pharmaceutical-grade chiral intermediate offered by Shenyang Mole Pharmaceutical Technology Development Co., Ltd., which trades the compound rather than manufacturing it directly. It is distributed across a broad set of markets including North and South America, Europe, Australasia, Asia, the Middle East and Africa, though no samples or further technical detail are currently provided.